SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037151
Filing Date
2023-08-02
Accepted
2023-08-02 16:09:12
Documents
85
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cere-20230630.htm   iXBRL 10-Q 3735488
2 EX-10.1 cere-ex10_1.htm EX-10.1 35849
3 EX-10.2 cere-ex10_2.htm EX-10.2 42836
4 EX-10.3 cere-ex10_3.htm EX-10.3 131945
5 EX-10.4 cere-ex10_4.htm EX-10.4 171827
6 EX-10.5 cere-ex10_5.htm EX-10.5 131400
7 EX-10.6 cere-ex10_6.htm EX-10.6 134998
8 EX-31.1 cere-ex31_1.htm EX-31.1 19000
9 EX-31.2 cere-ex31_2.htm EX-31.2 19009
10 EX-32.1 cere-ex32_1.htm EX-32.1 10809
11 EX-32.2 cere-ex32_2.htm EX-32.2 10830
12 GRAPHIC img33030426_0.jpg GRAPHIC 2035921
13 GRAPHIC img188942192_0.jpg GRAPHIC 3034
  Complete submission text file 0000950170-23-037151.txt   17995030

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cere-20230630.xsd EX-101.SCH 63565
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cere-20230630_cal.xml EX-101.CAL 57203
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cere-20230630_def.xml EX-101.DEF 260055
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cere-20230630_pre.xml EX-101.PRE 409799
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cere-20230630_lab.xml EX-101.LAB 521496
79 EXTRACTED XBRL INSTANCE DOCUMENT cere-20230630_htm.xml XML 2646256
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 231135600
SIC: 2834 Pharmaceutical Preparations